Abstract:BACKGROUND AND OBJECTIVESWe recently reported that hypoxia-mimetic agents cobalt chloride (CoCl2 CoCl2 ) and desferrioxamine (DFO) could induce differentiation of acute myeloid leukemic (AML) cells. Here, we investigate whether these two agents influence the in vitro differentiation-inducing effect of arsenic trioxide (As2O3) on AML cells, an effective drug for the treatment of acute promyelocytic leukemia (APL) that is a unique subtype of AML with a specific fusion protein, PML-RARalpha.DESIGN AND METHODSThe APL cell line NB4 and non-APL promonocytic leukemic cell line U937 were treated with As2O3 (0.5 microM) combined with CoCl2 (50 microM) or DFO (10 microM). The U937/PR9 subclone, whose expression of PML-RARalpha protein can be induced by Zn2+, was also investigated. Cellular differentiation was evaluated by morphological criteria and myeloid differentiation-related antigens and marker gene expression. The hypoxia-inducible factor-1alpha (HIF-1alpha) mRNA and protein were detected, respectively, by semi-quantitative/real-time quantitative reverse transcription polymerase chain reaction and immunoblots. PML-RARalpha protein was also analyzed.RESULTSCoCl2 and DFO potentiated the growth-inhibiting and differentiation-inducing effects of low-dose As2O3, the latter enhancing CoCl2 and DFO-induced accumulation of HIF-1alpha protein in NB4 cells but not in U937 cells. These two hypoxia-mimetic agents also accelerated As2O3-induced modulation and degradation of PML-RARalpha protein in NB4 cells. Furthermore, inducible expression of the fusion gene restored the co-operative effects of As2O3 and CoCl2/DFO on U937/PR9 cells in terms of growth arrest, differentiation induction and HIF-1alpha protein accumulation.INTERPRETATION AND CONCLUSIONSMimicked hypoxia enhanced As2O3-induced differentiation, in which HIF-1alpha and PML/RARalpha proteins played an important role. These data provide new insights into the understanding of the mechanisms of the action of As2O3 in the treatment of patients with APL.

Association of Oxidative Stress with Realgar-Induced Differentiation in Human Leukemia HL-60 Cells

Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells.

[Differentiation of HL-60 Cells Induced by Realgar Nano-Particles].

Induction of Human Promyelocytic Leukemia HL-60 Cell Differentiation into Monocytes by Arsenic Sulphide: Involvement of Serine/threonine Protein Phosphatases.

Metabolic Profiling Studies On The Toxicological Effects Of Realgar In Rats By H-1 Nmr Spectroscopy

The dual effects of realgar on acute promyelocytic leukemia cell:inducing apoptosis and promoting differentiation

Realgar-induced Apoptosis and Differentiation in All-Trans Retinoic Acid (Atra)-Sensitive NB4 and ATRA-resistant MR2 Cells

A clinical study of Realgar on ATRA-resistant acute promyelocytic leukemia and its effects on apoptosis induction

Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin–proteasome pathway

Anticancer Effect of Realgar Nanoparticles on Mouse Melanoma Skin Cancer in Vivo Via Transdermal Drug Delivery

Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro

Apoptosis, Redifferentiation and Arresting Proliferation Simultaneously Triggered by Oxidative Stress in Human Hepatoma Cells

Preparation Of Realgar Nanoparticle Suspension And Its Inhibition Effect On The Proliferation Of Human Myelocytic Leukaemia Hl-60 Cells

In Vitro Study on Realgar Induced Apoptosis of All-trans Acid Resistant Acute Promeylocytic Leukemia Cell Line (MR2)

Effects of Realgar on Telomerase Activity and Cell Apoptosis in K562 Cells

Study on the Mechanism of Reducing Hepatotoxicity of Water-Grinding Realgar by Metabolomics, Morphology, and Chemical Analysis

The Inherent Cellular Level of Reactive Oxygen Species: One of the Mechanisms Determining Apoptotic Susceptibility of Leukemic Cells to Arsenic Trioxide.

Oxidative Stress Response Induced by Chemotherapy in Leukemia Treatment (Review)

Effect of Ascorbic Acid Combined with Arsenic Trioxide on Apoptosis and Differentiation in Myelocytic Leukemia Cell Lines

Arsenic Trioxide-Induced Apoptosis and Differentiation Are Associated Respectively with Mitochondrial Transmembrane Potential Collapse and Retinoic Acid Signaling Pathways in Acute Promyelocytic Leukemia

Hypoxia-simulating Agents and Selective Stimulation of Arsenic Trioxide-Induced Growth Arrest and Cell Differentiation in Acute Promyelocytic Leukemic Cells.